Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype

Chest

Volumn 117, Issue 4, 2000, Pages 1085-1089

  Thomas, Stephen R ^b   Kharitonov, Sergei A ^a   Scott, Sandra F ^b   Hodson, Margaret E ^b   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Airway inflammation; Cystic fibrosis; Nitric oxide; Nitric oxide synthase

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY;

EID: 0034090782     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.4.1085     Document Type: Article

References (39)

1. 1 Shepherd MN. The pathology of cystic fibrosis. In: Geddes DM, Hodson ME, eds. Cystic fibrosis. London, UK: Chapman & Hall Medical, 1995; 131-150
2. 2 Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-1073
3. 3 Richman-Eisenstat JB, Jorens PG, Hebert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264:L413-L418
4. 4 Wilmott RW, Kassab JT, Kilian PL, et al. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990; 142:365-368
5. 5 Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-2118
6. 6 Berger M. Inflammation in the lung in cystic fibrosis: a vicious cycle that does more harm than good? In: Moss RB, ed. Cystic fibrosis: infection, immunopathology, and host response. Clifton, NJ: Humana Press, 1990; 119-142
7. 7 Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitric oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551
8. 8 Gustafsson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181:852-857
9. 9 Forstermann U, Schmidt HH, Pollock JS, et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 1991; 42:1849-1857
10. 10 Warner RL, Paine R, Christensen PJ, et al. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12:649-661
11. 11 Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510-1513
12. 12 Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
13. 13 Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151:1889-1893
14. 14 Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75:319-322
15. 15 Dotsch J, Demirakca S, Terbrack HG, et al. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996; 9:2537-2540
16. 16 Lundberg JO, Nordvall SL, Weitzberg E, et al. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 1996; 75:323-326
17. 17 Grasemann H, Michler E, Wallot M, et al. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997; 24:173-177
18. 18 Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102:1200-1207
19. 19 Cremona G, Higgenbottam T, Takao M, et al. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 1995; 78:59-63
20. 20 Persson MG, Wiklund NP, Gustafsson LE. Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 1993; 148:1210-1214
21. 21 Byrnes CA, Dinarevic S, Busst C, et al. Is nitric oxide in exhaled air produced at airway or alveolar level? Eur Respir J 1997; 10:1021-1025
22. 22 Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9:371-377
23. 23 Asono K, Chee CBE, Gaston B, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91:10089-10093
24. 24 Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-1370
25. 25 Kharitonov SA, Rajakulasingam K, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997; 99:58-64
26. 26 Khan TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:1075-1082
27. 27 Balough K, McCubbin M, Weinberger M, et al. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995; 20:63-70
28. 28 Salkowski CA, Detore G, McNally R, et al. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol 1997; 158:905-912
29. 29 Belvisi M, Barnes PJ, Larkin S, et al. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995; 283:255-258
30. 30 Meng QH, Springall DR, Bishop AE, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184:323-331
31. 31 Shori DK, Dormer RL, Goodchild MC, et al. Defective phosphorylation of a calmodulin-binding protein in cystic-fibrosis submandibular glands. Biochem J 1989; 263:613-616
32. 32 Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269:13725-13728
33. 33 Gharib R, Allen RP, Joos HA, et al. Paranasal sinusitis in patients with cystic fibrosis. Am J Dis Child 1964; 108:499-502
34. 34 Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1:370-373
35. 35 Warren JB Loi R, Rendell NB, et al. Nitric oxide is inactivated by the bacterial pigment pyocyanin. Biochem J 1990; 266:921-923
36. 36 Grasemann H, Ioannidis I, Tomkiewicz RP, et al. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998; 78:49-53
37. 37 Francoeur C, Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995; 19:587-598
38. 38 Mancinelli RL, McKay CP. Effects of nitric oxide on bacterial growth. Appl Environ Microbiol 1983; 46:198-202
39. 39 Jain B, Rubinstein I, Robbins RA, et al. TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am J Physiol 1995; 268:L911-L917